Edwards Syndrome
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Whole Blood Specimen Collection From Pregnant Subjects
Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Non-Invasive Screening for Fetal Aneuploidy
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
Comparison of Aneuploidy Risk Evaluations
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Non-Invasive Screening for Fetal Aneuploidy